Search Results - "MALLAT, Ariane"
-
1
Does CB-1 in hepatic stellate cells contribute to liver fibrosis?
Published in The Journal of clinical investigation (01-01-2022)Get full text
Journal Article -
2
Liver cirrhosis: intravoxel incoherent motion MR imaging--pilot study
Published in Radiology (01-12-2008)“…To retrospectively evaluate a respiratory-triggered diffusion-weighted (DW) magnetic resonance (MR) imaging sequence combined with parallel acquisition to…”
Get more information
Journal Article -
3
Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice
Published in Hepatology (Baltimore, Md.) (01-10-2011)“…Activation of Kupffer cells plays a central role in the pathogenesis of alcoholic liver disease. Because cannabinoid CB2 receptors (CB2) display potent…”
Get full text
Journal Article -
4
Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: A randomized trial comparing 3‐ and 6‐month periodicities
Published in Hepatology (Baltimore, Md.) (01-12-2011)“…Detection of small hepatocellular carcinoma (HCC) eligible for curative treatment is increased by surveillance, but its optimal periodicity is still debated…”
Get full text
Journal Article -
5
Autophagy: A Multifaceted Partner in Liver Fibrosis
Published in BioMed research international (01-01-2014)“…Liver fibrosis is a common wound healing response to chronic liver injury of all causes, and its end-stage cirrhosis is responsible for high morbidity and…”
Get full text
Journal Article -
6
Cannabinoid receptor 2 counteracts interleukin‐17‐induced immune and fibrogenic responses in mouse liver
Published in Hepatology (Baltimore, Md.) (01-01-2014)“…Interleukin (IL)‐17 is a proinflammatory and fibrogenic cytokine mainly produced by T‐helper (Th)17 lymphocytes, together with the hepatoprotective and…”
Get full text
Journal Article -
7
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Published in Nature medicine (01-06-2006)“…Hepatic fibrosis, the common response associated with chronic liver diseases, ultimately leads to cirrhosis, a major public health problem worldwide. We…”
Get full text
Journal Article -
8
Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)
Published in Hepatology (Baltimore, Md.) (01-10-2016)“…The aim of this work was to develop an individualized score for predicting hepatocellular carcinoma (HCC) in patients with hepatitis C (HCV)‐compensated…”
Get full text
Journal Article -
9
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication
Published in Hepatology (Baltimore, Md.) (01-10-2018)“…Data on extrahepatic cancers (EHCs) in compensated viral cirrhosis are limited. The objective of the prospective multicenter Agence Nationale de Recherche sur…”
Get full text
Journal Article -
10
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
Published in Gastroenterology (New York, N.Y. 1943) (01-03-2005)“…Background & Aims: Hepatic myofibroblasts are central for the development of liver fibrosis associated with chronic liver diseases, and blocking their…”
Get full text
Journal Article -
11
Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis
Published in PloS one (09-06-2009)“…Obesity-associated inflammation is of critical importance in the development of insulin resistance and non-alcoholic fatty liver disease. Since the cannabinoid…”
Get full text
Journal Article -
12
Hepatic fibrosis: Molecular mechanisms and drug targets
Published in Annual review of pharmacology and toxicology (01-01-2005)“…Liver fibrosis is the common response to chronic liver injury, ultimately leading to cirrhosis and its complications, portal hypertension, liver failure, and…”
Get full text
Journal Article -
13
Association of caffeine intake and histological features of chronic hepatitis C
Published in Journal of hepatology (01-06-2011)“…Background & Aims The severity of chronic hepatitis C (CHC) is modulated by host and environmental factors. Several reports suggest that caffeine intake exerts…”
Get full text
Journal Article -
14
EASL Recognition Award Recipient 2022: Dr. Sophie Lotersztajn
Published in Journal of hepatology (01-08-2022)Get full text
Journal Article -
15
Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis
Published in American Journal of Physiology: Cell Physiology (15-10-2013)“…Liver fibrosis is the common scarring reaction associated with chronic liver injury that results from prolonged parenchymal cell injury and/or inflammation…”
Get more information
Journal Article -
16
Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance
Published in JHEP reports (01-06-2021)“…In this study we aimed to analyse the impact of the aetiology of cirrhosis on the incidence, characteristics and prognosis of hepatocellular carcinoma (HCC)…”
Get full text
Journal Article -
17
Sphingosine 1-Phosphate Triggers Both Apoptotic and Survival Signals for Human Hepatic Myofibroblasts
Published in The Journal of biological chemistry (04-10-2002)“…Hepatic myofibroblasts (hMFs) are central in the development of liver fibrosis during chronic liver diseases, and their removal by apoptosis contributes to the…”
Get full text
Journal Article -
18
Adipose Tissue Macrophages: MR Tracking to Monitor Obesity-associated Inflammation
Published in Radiology (01-06-2012)Get full text
Journal Article -
19
Targeting cell-intrinsic metabolism for antifibrotic therapy
Published in Journal of hepatology (01-06-2021)“…In recent years, there have been major advances in our understanding of the mechanisms underlying fibrosis progression and regression, and how coordinated…”
Get full text
Journal Article -
20
Matrix metalloproteinase‐2 activation in human hepatic fibrosis regulation by cell‐matrix interactions
Published in Hepatology (Baltimore, Md.) (01-10-1999)“…Matrix metalloproteinase‐2 (MMP‐2) is involved in extracellular matrix remodeling. It is secreted as a proenzyme and activated by membrane type‐MMPs (MT‐MMP),…”
Get full text
Journal Article